Good afternoon, and welcome to the MannKind Corporation conference call to discuss the U.S. FDA approval of Afrezza in pediatrics. As a reminder, this call is being recorded on May 29, 2026, and will ...
Morning Overview on MSN
A single-patch sensor now reads blood sugar through the skin with no needle stick — and the first versions are already on their way to pharmacy shelves
For decades, checking blood sugar meant the same routine: a lancet, a test strip, a drop of blood, and a number that told you ...
Glucotrack has made great strides over the past several years as it advances its implantable continuous blood glucose monitor ...
New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical ...
Glucose monitoring has come a long way since pricking your finger every day. Now there are continuous glucose monitors, which ...
A new study published in Nature Metabolism offers a look at what happens inside the brain cells targeted by semaglutide, the ...
A CGM is about the size of two stacked quarters, but its purpose is important.
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...
For decades, watching your blood sugar move in real time required a prescription, a finger prick or both. That barrier is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results